UNITE: Efficacy and impact of fremanezumab in patients with migraine and major depressive disorder

被引：0
|
作者：
Ramirez Campos, V. [1 ]
Lipton, R. B. [2 ]
Krasenbaum, L. J. [1 ]
Ning, X. [1 ]
Barbanti, P. [3 ,4 ]
Roth-Ben Arie, Z. [5 ]
Galic, M. [6 ]
Denysenko, L. [7 ,8 ]
Marmura, M. [7 ]
McAllister, P. [9 ]
Mitsikostas, D. D. [10 ]
机构：
[1] Teva Branded Pharmaceut Prod R&D Inc, W Chester, PA USA
[2] Albert Einstein Coll Med, Dept Neurol Psychiat & Behav Sci, New York, NY USA
[3] IRCCS San Raffaele Roma, Headache & Pain Unit, Rome, Italy
[4] San Raffaele Univ, Rome, Italy
[5] Teva Pharmaceut Ind Ltd, Petah Tiqwa, Israel
[6] TEVA PHARMA, Prod Farmaceut Lda, Porto Salvo, Portugal
[7] Thomas Jefferson Univ Hosp, Dept Neurol, Jefferson Headache Ctr, Philadelphia, PA 19107 USA
[8] Thomas Jefferson Univ Hosp, Dept Psychiat & Human Behav, Philadelphia, PA 19107 USA
[9] New England Inst Neurol & Headache, Stamford, CT USA
[10] Natl & Kapodistrian Univ Athens, Aeginit Hosp, Dept Neurol 1, Athens, Greece
来源：
JOURNAL OF HEADACHE AND PAIN | 2024年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P028
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Efficacy of vilazodone on anxiety symptoms in patients with major depressive disorder
    Thase, Michael E.
    Chen, Dalei
    Edwards, John
    Ruth, Adam
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2014, 29 (06) : 351 - 356
  • [32] Personality Modulates the Efficacy of Treatment in Patients With Major Depressive Disorder
    Wardenaar, Klaas J.
    Conradi, Henk Jan
    Bos, Elisabeth H.
    de Jonge, Peter
    JOURNAL OF CLINICAL PSYCHIATRY, 2014, 75 (09) : E916 - E923
  • [33] Efficacy of Fremanezumab in Patients With Lower and Higher Frequency Chronic Migraine
    McAllister, Peter
    Cohen, Joshua M.
    Ning, Xiaoping
    Campos, Verena Ramirez
    Barash, Steve
    Ashina, Messoud
    NEUROLOGY, 2021, 96 (15)
  • [34] Efficacy of Quarterly and Monthly Fremanezumab in Patients With Migraine and Psychiatric Comorbidities
    Lipton, Richard B.
    Ning, Xiaoping
    Barash, Steve
    Akcicek, Hasan
    Lyras, Leonidas
    Buse, Dawn C.
    CEPHALALGIA, 2022, 42 (1_SUPPL) : 40 - 41
  • [35] Efficacy of Fremanezumab in Patients With Moderate and Higher Frequency Episodic Migraine
    Nahas, Stephanie J.
    Ning, Xiaoping
    Cohen, Joshua M.
    Barash, Steve
    Campos, Verena Ramirez
    Silberstein, Stephen D.
    NEUROLOGY, 2021, 96 (15)
  • [36] The comorbidity of major depressive disorder, dysthymic disorder and anxiety disorders with migraine
    Cardona-Castrillon, G. P.
    Isaza, R.
    Zapata-Soto, A. P.
    Franco, J. G.
    Gonzalez-Berrio, C.
    Tamayo-Diaz, C. P.
    REVISTA DE NEUROLOGIA, 2007, 45 (05) : 272 - 275
  • [37] Efficacy and tolerability of fremanezumab for migraine preventive treatment in Korean patients with chronic or episodic migraine
    Kim, Byung-Kun
    Cohen, Joshua
    Kim, Sukyung
    Chang, Daeho
    Ning, Xiaoping
    Lengil, Tamar
    Janka, Lindsay
    Barash, Steve
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 214 - 214
  • [38] Efficacy of Vortioxetine on Cognitive Functioning in Working Patients With Major Depressive Disorder
    McIntyre, Roger S.
    Florea, Ioana
    Tonnoir, Brigitte
    Loft, Henrik
    Lam, Raymond W.
    Christensen, Michael Cronquist
    JOURNAL OF CLINICAL PSYCHIATRY, 2017, 78 (01) : 115 - 121
  • [39] Efficacy of Adjunctive Brexpiprazole in Patients with Major Depressive Disorder: A Clinical Overview
    Thase, Michael E.
    Zhang, Peter
    Skuban, Aleksandar
    Hobart, Mary
    Weiss, Catherine
    Weiller, Emmanuelle
    Nelson, James C.
    CURRENT PSYCHIATRY REVIEWS, 2016, 12 (03) : 291 - 301
  • [40] EFFICACY AND TOLERABILITY OF VENLAFAXINE EXTENDED RELEASE IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER
    Plesnicar, Blanka Kores
    PSYCHIATRIA DANUBINA, 2010, 22 (03) : 413 - 417
12345